In compliance with this result, clinical breast cancer samples analysis confirmed that IL-6R expression was significantly associated with tamoxifen resistance in breast cancer tissues, with high IL-6R expression correlated with poor survival (113). The gene discussed is IL6R; the disease is breast cancer.